• Korean Journal of Pharmacognosy
• /
• v.51 no.3
• /
• pp.217-221
• /
• 2020

Cirsium japonicum var. maackii (CM) has been used to treat certain medical conditions such as hemorrhage, hepatitis, and hypertension. Cirsimaritin was previously found as the major flavonoid in CM and is said to contribute to its pharmacological effects. There are currently no reports detailing the qualitative and quantitative detection of phytochemical indicators in the aerial parts of CM. Therefore, we developed a method to rapidly identify and quantify cirsimaritin in CM using HPLC/UV, and we optimized and validated this analytical method. The results showed good linearity in the concentration range tested (0.25-0.015 mg/mL, r² ≥ 0.9999), accuracy (93.9-111.3%), and precision (RSD ≤ 0.59%). The developed method can therefore be used for the rapid evaluation of cirsimaritin in CM.

• Journal of the Korean Society of Food Science and Nutrition
• /
• v.25 no.4
• /
• pp.588-592
• /
• 1996

The flavonoids isolated from Oenanthe javanica were investigated on the antimutagenic effect againt aflatoxin $B_1(AEB_1).$ The 0.5 and 1.0mg/plate of isorhamnetin reduced the mutagenicity of $AFB_1about$ 33 and 59%, respectively. Persicarin showed the 40 and 47% inhibition rate at Previous concentration, respectively.

• Journal of Applied Biological Chemistry
• /
• v.61 no.3
• /
• pp.227-232
• /
• 2018

Simultaneous determination of three methoxyflavones, namely, cirsimarin (1), hispidulin (2), and cirsimaritin (3) in selected Korean thistles was performed via reversed-phase high performance liquid chromatography system. Compound 1 was present in all the thistle species examined, whereas 2 and 3 were only detected in Cirsium japonicum and C. japonicum var. maackii (CJM). The concentration of compounds 1-3 in CJM varied according to the time of harvest. Plants collected in the spring (CJMS) and fall (CJMF) had the highest contents of 3 and 1, respectively. A lower content of 2 was observed in CJMF than in CJMS. This indicates that seasonal variation affects the flavonoid content of CJM. The results of this study show that CJM is an excellent source of compounds 1-3 and it can potentially be cultivated for industrial and pharmaceutical applications involving these compounds.

• Natural Product Sciences
• /
• v.6 no.4
• /
• pp.179-182
• /
• 2000

Nine compounds were isolated from the fruit Citrus junos. Their structures were elucidated as 9-hydroxy-4-methoxypsoralen, auraptene, limonin, deacetylnomilin, cirsimaritin, narirutin, naringin, hesperidin and neohesperidin by physico-chemical evidences. 9-Hydroxy-4-methoxypsoralen and auraptene have not been reported from C. junos yet.

• Korean Journal of Pharmacognosy
• /
• v.33 no.2 s.129
• /
• pp.81-84
• /
• 2002

Three norisoprenoids (2, 4 and 5) were isolated from the aerial parts of Cirsium rhinoceros (Compositae) together with three flavonoids, pectolinarigenin (1), apigenin (3) and cirsimaritin (6). The structures of norisoprenoids were identified as dehydrovomifoliol (2), (+)-loliolide (4) and (-)-epiloliolide (5) on the basis of physico-chemical and spectral evidences. These norisoprenoids were first repoted from Cirsium species.

• The Korea Journal of Herbology
• /
• v.38 no.4
• /
• pp.31-43
• /
• 2023

Objectives : The objective of this study was to investigate the phytochemistry and pharmacological activities of Cirsium setidens. Methods : Domestic and international articles about Cirsium setidens were investigated. A review was perfoemed via DB searching engine such as Sci.Direct, Springer, DBpia, KISS, Google scholar, Kipris, and so on. Total 73 listed literature were classified by compound analysis and pharmacological efficacy. Results : C. setidens contains pectolinarin and its glycoside, pectolinarigenin as index compounds, and linarin, apigenin, diosmetin, scopoletin, acacetin, cirsimarin, cirsimaritin, setidenosides A and B, silymarin, hispidulin, 92 volatile compounds, and 15 fatty acids. The Pharmacological activities of C. setidens has been reported to inhibit of platelet aggregation and fat accumulation in the liver, inhibit to hepatitis, anti-cancer, antibacterial, skin improvement, hair growth, liver protection, anti-diabetic, anti-inflammatory, sedative. Also, It has been reported the effect of cholesterol-lowering and anti-obesity, neuroprotective effects, increasing human stem cell viability, inhibiting osteoclast formation and osteogenic differentiation. Conclusion : This reviews showed that C. setidens which has been traditionally used for the treatment of inflammation and hypertension, has anticancer and river protective effect, as well as hair loss and diet. In order to maximize the efficacy of C. setidens, research has also begun on the effect of processing processes such as fermentation or fine powdering and combining natural plant resources.

• Proceedings of the Plant Resources Society of Korea Conference
• /
• 2019.10a
• /
• pp.93-93
• /
• 2019

골관절염은 연골 파괴 및 연골 형성의 손상을 초래하는 산화 스트레스 세포사와 관련된 염증성 질환이다. 최근에, 엉겅퀴(Cirsium japonicum var. maackii)는 다양한 염증성 질환에 대하여 보호하는 역할을 하는 것으로 보고되었습니다. 그러나, 연골 퇴행 및 골관절염 진행에 대한 엉겅퀴의 역할은 아직 알려져 있지 않았다. 따라서, 본 연구는 골관절염 및 연골 분해 생쥐 모델에서 엉겅퀴의 보호 효과를 조사하였다. 먼저, 엉겅퀴의 활성 성분 함량을 측정하기 위해 총 폴리페놀 함량과 총 플라보노이드 함량 분석을 수행하였다. 그 결과, 건조된 엉겅퀴 지상부의 물 추출물에서 총 폴리페놀 함량은 $149.2{\pm}24.1mg\;GAE/g$ 및 총 플라보노이드 함량은 $27.9{\pm}2.0mg\;NE/g$을 함유하는 것으로 밝혀졌다. 또한, HPLC 분석으로부터 엉겅퀴 지상부 물 추출물의 주요 화합물은 플라보노이드 계열인 cirsimarin과 cirsimaritin으로 확인되었다. 또한, 엉겅퀴 추출물은 조직 병리학적 분석에 의해 입증된 내측 반월판의 불안정화에 의해 유도된 골관절염 마우스 모델에서 연골파괴 억제효과를 나타냈다. 결론적으로, 본 연구결과는 엉겅퀴 추출물이 골관절염과 연골 파괴를 개선 또는 예방할 수 있는 새로운 식 의약 소재로의 개발 가능성을 제시한다.